ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,644, issued on Aug. 18, was assigned to Excoso a.s. (Prague).
"Dendritic cell vaccination sequential to chemotherapy" was invented by Radek Spisek (Prague) and Jirina Bartunkova (Prague).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of a dendritic cell vaccination sequential to chemotherapy, wherein the dendritic cell vaccine is administered to a patient after completion of chemotherapy with at least one chemotherapeutic agent."
The patent was filed on Jan. 25, 2019, under Application No. 16/964,847.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/...